Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus.
Ontology highlight
ABSTRACT: Type 1 diabetes mellitus (T1DM) is an autoimmune-mediated disease characterized by a reduced or absolute lack of insulin secretion and often associated with a range of vascular and neurological complications for which there is a lack of effective treatment other than lifestyle interventions and pharmacological treatments such as insulin injections. Studies have shown that the gut microbiota is involved in mediating the onset and development of many fecal and extrafecal diseases, including autoimmune T1DM. In recent years, many cases of gut microbiota transplantation for diseases of the bowel and beyond have been reported worldwide, and this approach has been shown to be safe and effective. Here, we conducted an experimental treatment study in two adolescent patients diagnosed with autoimmu
SUBMITTER: He L
PROVIDER: S-EPMC9414079 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA